Gene: MFSD4A
Official Full Name: major facilitator superfamily domain containing 4Aprovided by HGNC
Gene Summary: Predicted to enable D-glucose transmembrane transporter activity. Predicted to be involved in hexose transmembrane transport. Predicted to be located in membrane. Biomarker of cholangiocarcinoma. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23248 | MFSD4A Knockout cell line (HCT 116) | Human | MFSD4A | 1:2~1:4 | Negative | Online Inquiry |
KO23249 | MFSD4A Knockout cell line (A549) | Human | MFSD4A | 1:3~1:4 | Negative | Online Inquiry |
MFSD4A Gene Knockout Cell Lines are cutting-edge biological tools specifically engineered to facilitate the study of the function and role of the MFSD4A gene. The MFSD4A gene is implicated in various cellular processes, including lipid transport and membrane dynamics, and its knockout allows researchers to investigate the gene's contributions to health and disease. By utilizing CRISPR-Cas9 technology, these cell lines are generated to create precise deletions of the MFSD4A gene, offering a reliable model for understanding gene function and regulation within various biological contexts.
The principal mechanism of these knockout cell lines involves the inhibition of MFSD4A protein expression, which enables researchers to explore downstream signaling pathways and the physiological consequences of its absence. With comprehensive analyses facilitated by these models, scientists can assess how the disruption of MFSD4A impacts cellular functions, including metabolic processes, cellular signaling, and pathological conditions related to cancer and neurodegenerative diseases.
In research and clinical settings, MFSD4A Gene Knockout Cell Lines hold significant scientific importance. They provide tangible insights into gene function that could lead to novel therapeutic strategies for diseases where MFSD4A plays a crucial role. This makes them indispensable for drug discovery and development endeavors that require a detailed understanding of specific genetic contributions to disease phenotypes.
What sets MFSD4A Gene Knockout Cell Lines apart from alternative models is their high specificity and robustness, ensuring reproducibility and consistency in experimental outcomes. Unlike less targeted approaches, these cell lines circumvent the issues posed by off-target effects often seen in older gene editing techniques. Additionally, their ease of use and integration into existing laboratory workflows enhances their accessibility for a broad range of researchers.
Researchers and clinicians are encouraged to leverage MFSD4A Gene Knockout Cell Lines as a vital asset in their investigations, especially for those seeking to illuminate the pathways and mechanisms involving MFSD4A. By investing in these knockout lines, users can accelerate their research into gene-related conditions and expand their understanding of critical biological functions.
With extensive expertise in genetic engineering and a commitment to advancing research tools, our company is dedicated to delivering high-quality biological products that empower researchers to make groundbreaking discoveries in the field of genetics and cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.